Posted Feb. 27, 2013 at 10:34 a.m.

Premium Lock GSK joint venture strikes patent deal to lower HIV drug costs for children

Published: 2013-02-27 10:34:01
Updated: 2013-02-27 10:34:01

HIV AIDS research   HIV AIDS research

ViiV Healthcare, a joint venture of GlaxoSmithKline and two other drugmakers, plans to license pediatric versions of its HIV drug abacavir to a patent-sharing body backed by the United Nations to improve children's access to treatment and lower costs....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders